INSIGHTS ON DRUG DEVELOPMENT
-
Nanomedicine Modalities Find Path To Clinic Through Analytics
Lipid nanoparticles have revolutionized drug delivery, ushering in a new era of nanomedicine. Discover how advanced analytical tools are accelerating next-generation LNP therapeutics.
-
Assessing E&Ls From Single-Use Systems Used In ATMP Production
Explore the impact of extractables and leachables (E&Ls) in CGT development. Learn how to qualify single-use systems and use cell-painting assays to assess E&L effects.
-
Next Generation Conjugates: Process And Analytical Challenges
Explore specific examples of challenges commonly encountered in the process and analytical development of next-generation conjugates as well as corresponding solutions for each.
-
3D Neurospheres In Healthy And Alzheimer's: iPSC-Derived Neurons
Explore how different ApoE alleles influence Alzheimer's Disease risk using iPSC-derived neurons as well as gain insights into AD mechanisms and potential therapies.
-
VEGF Signaling Pathway3/24/2025
In Alzheimer's disease, reduced VEGF levels are linked to neurodegeneration, which can offer therapeutic potential. Discover how experimental treatments show promise in reducing memory impairment and beta-amyloid deposition.
-
A Holistic Approach To Understanding High And Low HEK293 Producer4/4/2025
Despite advancements in AAV-based gene therapy, key aspects of AAV biology and production remain unclear. Find out how researchers are exploring HEK293 subclones to identify traits that enhance viral vector yields.
-
Together, Let's Sail Toward Success7/23/2025
Explore the promise and complexity of gene therapy and see how Cytiva empowers scientists to overcome challenges and accelerate life-changing treatments from lab to patient.
-
Accelerating mRNA Therapy Production With Digital Innovation10/21/2025
Scaling mRNA therapies requires more than innovation—it demands precision. Discover how digital tools like automation and analytics are helping life science companies streamline production.
-
Automation Of 3D Intestinal Organoids Culture3/17/2025
Gain insight into how 3D organoids promise better disease modeling and drug screening and how challenges like assay complexity, reproducibility, and scalability hinder their widespread adoption in drug discovery.
DRUG DEVELOPMENT SOLUTIONS
-
Routine cell culture? Check!
For researchers who need consistent experimental outcomes, Mateo TL enables all lab members to check and document cell growth status conveniently and comfortably.
Measure confluency consistently, thereby increasing the confidence in the success of their downstream experiments.
-
Research Use Only (RUO) lipid nanoparticle (LNP) reagents to deliver RNA into hematopoietic stem cells (HSCs) for cell and gene therapy applications.
-
MabSelect™ VL resin — protein L resin for affinity capture of antibody Fabs, bispecifics, and other variants containing a kappa light chain.
-
When it comes to solid dosage formulations, the most common challenge formulators face is poor solubility. In numbers: 70% of drugs in development are poorly soluble.
-
Used Carl Zeiss Microscope, with AxioCam MRc5 and H.I.P controls, CE design, serial# 39180008000.